Skip to main content
logo
Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,980.00
-210.00 (-2.92%)
At close: Sep 16, 2026

KOSDAQ:318160 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,5668,7214,379-1,8572,8903,131
Depreciation & Amortization
3,0282,4341,9061,8031,8611,539
Loss (Gain) From Sale of Assets
-22.95-181.58-12.55218.1519.1763.68
Asset Writedown & Restructuring Costs
---372.86-308.07
Loss (Gain) From Sale of Investments
-5.54-6.81-5-10.2-1,500
Stock-Based Compensation
-----141.91
Provision & Write-off of Bad Debts
348.16409.38-37.26326.3687.8417.06
Other Operating Activities
-1,055-186.75-1,4873,527-748.18842.36
Change in Accounts Receivable
-2,552-5,799339.63-1,5261,1361,140
Change in Inventory
-6,266-7,5234,384344.4-2,516-3,192
Change in Accounts Payable
-221.131,6311,586202.36-1,5903.93
Change in Other Net Operating Assets
2,9531,988-1,782-1,641-701.91,719
Operating Cash Flow
6,7731,4879,2711,759437.87,614
Operating Cash Flow Growth
359.66%-83.96%426.97%301.84%-94.25%104.51%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13,187-6,638-2,024-627.84-360.31-3,725
Sale of Property, Plant & Equipment
691.621,240116.5826.7432.571.05
Cash Acquisitions
---11,488--
Divestitures
130.05163.05---202
Sale (Purchase) of Intangibles
-513.51-170.75-1.99-504.87-14.63-124.48
Investment in Securities
1,2729,446-2,159-7,4025,033-1,072
Other Investing Activities
-243.59-169.32-567.52-351-671.19112.98
Investing Cash Flow
-10,9243,801-4,6432,6304,020-4,535

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,2593,6751,3875,3424,535
Long-Term Debt Issued
-9,500----
Total Debt Issued
17,20212,7593,6751,3875,3424,535
Short-Term Debt Repaid
--3,133-6,332--5,008-
Long-Term Debt Repaid
--255-165.97-6,182-14,234-217.48
Total Debt Repaid
-8,938-3,388-6,498-6,182-19,242-217.48
Net Debt Issued (Repaid)
8,2649,372-2,823-4,795-13,9004,317
Issuance of Common Stock
364.96364.96----
Repurchase of Common Stock
-822.88-2,197-2,796-37.25--
Other Financing Activities
-5.417.3-5-5-
Financing Cash Flow
7,8017,547-5,623-4,832-13,8954,317

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
128.69-16.7142.60.583.59280.38
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
3,77912,818-953.01-442.28-9,4347,676

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6,415-5,1517,2471,13177.493,889
Free Cash Flow Growth
--540.50%1360.05%-98.01%-
Free Cash Flow Margin
-10.53%-10.09%25.50%4.14%0.28%11.06%
Free Cash Flow Per Share
-772.41-627.58812.26133.9111.07492.62
Levered Free Cash Flow
-14,407-10,9975,6302,010-1,0152,592
Unlevered Free Cash Flow
-13,846-10,7985,8872,315-730.292,975

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
47.51180.07920.98913.78494.66315.16
Cash Income Tax Paid
524.97745.9791809.632,074428.79
Change in Working Capital
-6,085-9,7034,528-2,621-3,672-329.76